-  HHS Family of Agencies      -  HHS Agencies & Offices 
  -  Regional Offices 
  -  Advisory Committees, Task Forces & Initiatives 
  -  Organizational Chart 
-  Leadership 
-  Budget & Performance      -  FY 2025 Budget in Brief 
  -  FY 2025 Annual Performance Plan and Report 
  -  FY 2024 Contingency Staffing Plan 
  -  FY 2024 Budget in Brief 
  -  FY 2024 Annual Performance Plan and Report 
  -  FY 2023 Contingency Staffing Plan 
  -  FY 2023 Budget in Brief 
  -  FY 2023 Annual Performance Plan and Report 
  -  FY 2022 Contingency Staffing Plan 
  -  FY 2022 Budget in Brief 
  -  FY 2022 Annual Performance Plan and Report 
  -  FY 2021 Contingency Staffing Plan 
  -  FY 2021 Budget in Brief 
  -  FY 2021 Annual Performance Plan and Report 
  -  FY 2020 Contingency Staffing Plan 
  -  FY 2020 Budget in Brief 
  -  FY 2020 Annual Performance Report 
  -  FY 2019 Contingency Staffing Plan 
  -  FY 2019 Annual Performance Report 
-  Strategic Plan FY 2022 - 2026      -  Message from the Secretary 
  -  Introduction: About HHS 
  -  Overview: Strategic Plan FY 2022 - 2026 
  -  Strategic Goal 1: Protect and Strengthen Equitable Access to High Quality and Affordable Healthcare 
  -  Strategic Goal 2: Safeguard and Improve National and Global Health Conditions and Outcomes 
  -  Strategic Goal 3: Strengthen Social Well-Being, Equity, and Economic Resilience 
  -  Strategic Goal 4: Restore Trust and Accelerate Advancements in Science and Research for All 
  -  Strategic Goal 5: Advance Strategic Management to Build Trust, Transparency, and Accountability 
  -  Appendix: Plan Updates 
-  News 
-  I Am HHS 
-  Careers 

                      -   
                      -   
                      -   
                      -   
                      -   

# FY 2019 Annual Performance Plan and Report - Goal 2 Objective 4

**Topics on this page:**Goal 2. Objective 4 | Objective 2.4 Table of Related Performance Measures

----

## Goal 2.  Objective 4:  Prepare for and respond to public health emergencies

The health of Americans during public health emergencies and other incidents depends on the effectiveness of preparedness, mitigation, response and recovery efforts.  Threats in an increasingly interconnected, complex, and dangerous world include naturally emerging infectious diseases; frequent and severe weather events; state and non-state actors that have access to chemical, biological, radiological, or nuclear agents; non-state actors who commit acts of mass violence; and cyber attacks on health care systems and infrastructure.

HHS is working to ensure that a national disaster health care system is integrated within the health care delivery infrastructure—hospitals, emergency medical services, emergency management, and public health agencies—to provide safe and effective health care during emergencies and other disasters.  In addition, National Disaster Medical System teams and the U.S. Public Health Service Commissioned Corps complement non-Federal efforts during incidents. HHS supports local Medical Reserve Corps units, which supplement the capacity of States, Tribes, localities, and territories. Through direct services and partnerships with State, Tribal, local, and territorial governments, with faith-based and community organizations, and with the private sector, HHS works to strengthen the Nation’s emergency preparedness, response, and recovery efforts.

HHS is engaged in the research, development, and procurement of medical countermeasures, including vaccines, drugs, therapies, and diagnostic tools.  HHS collaborates with others to ensure that the appropriate number of safe and effective medical countermeasures are developed and stockpiled and can be easily distributed and used to save lives during an incident.

HHS invests in building the capacity of other countries to detect, prevent, and respond to incidents—thus providing early warning to or reducing the impact to the United States.  The international public health professionals trained by the Global Disease Detection Operations Center monitor 30 to 40 public health events each day, and can deploy within 24 hours of learning about an outbreak.

The Office of the Secretary leads this objective.  The following divisions are responsible for implementing programs under this strategic objective: ACF, ACL, ASA, ASPA, ASPR, CDC, CMS, FDA, HRSA, IHS, IOS, NIH, OASH, OCR, OGA, and SAMHSA.

### Objective 2.4 Table of Related Performance Measures

#### *Increase the percentage of CDC-funded Public Health Emergency Preparedness state and local public health agencies that can convene, within 60 minutes of notification, a team of trained staff that can make decisions about appropriate response and interaction with partners (Lead Agency - CDC; Measure ID - 13.5.3)*17

Public health agencies must be able to rapidly convene key management staff (within 60 minutes of being notified) to appropriately respond to an emergency.  This effort includes the integration of information and the prioritization of resources to ensure timely and effective coordination within the public health agency and key response partners.  In FY 2015, 100% of PHEP-funded public health agencies convened trained staff within 60 minutes of notification to make decisions regarding partner engagement and incident response, exceeding the FY 2015 target and representing an 11 percentage point increase from FY 2012.  In FY 2018 and 2019, CDC will continue to work with awardees to improve results and achieve future targets.

#### *Increase the number of new licensed medical countermeasures within Biomedical Advanced Research and Development Authority (BARDA) (Lead Agency - ASPR; Measure ID - 2.4.13a)*

In support of HHS strategies for public health emergency preparation and response, ASPR reports the number of new licensed medical countermeasures, which are regulated products (biologics, drugs, devices) that may be used in the event of a potential public health emergency stemming from a terrorist attack with a biological, chemical, or radiological/nuclear material, a naturally occurring emerging disease, or a natural disaster.  For FY 2017, BARDA reported 5 new medical countermeasures. In addition to chemical, biological, radiological, and nuclear defense, the new countermeasures address influenza, broad spectrum antimicrobials, and Zika.  The FY 2017 target for this measure was 3.  The FY 2017 was exceeded.  The FY 2018 and FY 2019 targets are 3 for each respective year.  The targets were set based on resource expectations and overall priorities.  In FY 2018 and 2019, ASPR will continue to monitor progress towards an agile, robust and sustainable U.S. manufacturing infrastructure capable of rapidly producing vaccines and other biologics against pandemic influenza and other emerging threats.

----

[17] CDC results are based on jurisdictions (N) that allocated PHEP funding for pulsed-field gel electrophoresis E.coli activities.

----

<< Return to Topics in this Report

Top of page

Goal 3 Objective 1 >>

Content last reviewed September 19, 2022